Dear Editor,

We read with interest the article “Pulmonary Rehabilitation in Patients Recovering from COVID-19,” [1] and we would like to congratulate the authors for the initiative and approach. As we are also conducting a pulmonary rehabilitation program (PRP) in these patients, we would like to discuss aspects concerning physiopathology and reinforce the role of PRP.

The COVID-19 pandemic has been a challenge for health-care systems due to its severity and its manifestations after stabilization of infection. The integrality of health-care systems must be able to rehabilitate them.

The severity of COVID-19 can be categorized into mild form, with the majority of cases (asymptomatic/minimal symptoms); severely ill, requiring hospitalization and supplemental oxygenation; and critical, requiring invasive mechanical ventilation [2].

Because of severe acute respiratory syndrome (SARS)-CoV-2 infection, multiple mechanisms lead to impaired oxygenation to the tissues. The first mechanism, the pulmonary diffusion prejudice, is related to mismatch at ventilation/perfusion. The second mechanism, cardiovascular and oxygen transport impairments, is associated to acute cardiac injury, acute coronary event, left ventricular systolic dysfunction, heart failure, arrhythmia, and coagulation abnormalities [3, 4]. Additionally, there is a decrement in hemoglobin counts and an increase in erythrocyte sedimentation [5].

The third mechanism is deconditioning of skeletal muscles. In patients with SARS, there is a generalized atrophy with necrosis in muscle fibers, myofibril disarray, and Z-disc streaming [6]. In these patients, a reduction of 32% at handgrip and 13% of distance walked in the 6-min walk test (6MWT) [7] is expected. In SARS-CoV-2, there are peripheral neurologic perturbations due to the use of corticosteroids and neuromuscular blocking agents and elevations in blood sugar. Additionally, age, muscular functional state before infection, comorbidities, muscular damage path, and nutritional state contribute for muscular damage.

Facing these phenomena, a PRP should encompass aerobic and force exercises to improve oxygen supply and global function (Fig. 1). For some patients, we may find desaturation with minimal efforts, and supplemental oxygen and/or noninvasive ventilatory support should be necessary. In our preliminary data, some patients who were initially enrolled as dependent on oxygen were able to realize an entire session without it. So far, none presented an adverse/unexpected event, and they were able to increase the intensity of exercise.

Fig. 1.

Global mechanisms involved in decreased O2 to tissues concerning (SARS)-CoV-2 infecction and the role of a pulmonary rehabilitation program.

Fig. 1.

Global mechanisms involved in decreased O2 to tissues concerning (SARS)-CoV-2 infecction and the role of a pulmonary rehabilitation program.

Close modal

The article [1] presented important information about physical improvements from a PRP. Nevertheless, the study did not evaluate changes in ergospirometry, neither maximal force generated by maximal voluntary contraction. We are being able to evaluate them more vigorously and, perhaps, conduct a more vigorous routine of exercises. As the authors, we agree that a PRP must adapt the protocol to each patient’s condition. Within this purpose, we found improvements of 10% at distance walked in the 6MWT and 12% at maximal voluntary contraction.

The long-term effects of PRP on pulmonary function of these patients are not yet known. We know from studies on survivors of SARS 2003 that pulmonary interstitial damage is associated to a functional decline, which is mostly recovered after rehabilitation [8]. By analogy, it may be assumed that it will be the same in cases of COVID-19.

There are no conflicts of interest with respect to this letter to the editor and the study associated.

There are no sources of financial support with respect to this letter to the editor and the study associated.

All the authors contributed to literature search, manuscript preparation, and analysis and interpretation concerning data mentioned in this letter. Karissa Yasmim Araújo Rosa, Felipe Xavier de Melo, and Dante Brasil Santos contributed to the revision of the manuscript and to data collection concerning information mentioned in this letter. Any data or information concerning this letter to the editor and the study associated were previously presented elsewhere.

1.
Zampogna
E
,
Paneroni
M
,
Belli
S
,
Aliani
M
,
Gandolfo
A
,
Visca
D
,
Pulmonary rehabilitation in patients recovering from COVID-19
.
Respiration
.
2021
;
100
(
5
):
416
22
. .
2.
Guan
WJ
,
Ni
ZY
,
Hu
Y
,
Liang
WH
,
Ou
CQ
,
He
JX
,
Clinical characteristics of coronavirus disease 2019 in China
.
N Engl J Med
.
2020 Apr 30
;
382
(
18
):
1708
20
. .
3.
Kwenandar
F
,
Japar
KV
,
Damay
V
,
Hariyanto
TI
,
Tanaka
M
,
Lugito
NPH
,
Coronavirus disease 2019 and cardiovascular system: A narrative review
.
Int J Cardiol Heart Vasc
.
2020 Aug
;
29
:
100557
. .
4.
Lodigiani
C
,
Iapichino
G
,
Carenzo
L
,
Cecconi
M
,
Ferrazzi
P
,
Sebastian
T
,
Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy
.
Thromb Res
.
2020
;
191
:
9
14
. .
5.
Chen
N
,
Zhou
M
,
Dong
X
,
Qu
J
,
Gong
F
,
Han
Y
,
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
.
Lancet
.
2020
;
395
(
10223
):
507
13
. .
6.
Leung
TW
,
Wong
KS
,
Hui
AC
,
To
KF
,
Lai
ST
,
Ng
WF
,
Myopathic changes associated with severe acute respiratory syndrome: a postmortem case series
.
Arch Neurol
.
2005 Jul
;
62
(
7
):
1113
7
. .
7.
Lau
HM
,
Lee
EW
,
Wong
CN
,
Ng
GY
,
Jones
AY
,
Hui
DS
.
The impact of severe acute respiratory syndrome on the physical profile and quality of life
.
Arch Phys Med Rehabil
.
2005 Jun
;
86
(
6
):
1134
40
. .
8.
Files
DC
,
Sanchez
MA
,
Morris
PE
.
A conceptual framework: the early and late phases of skeletal muscle dysfunction in the acute respiratory distress syndrome
.
Crit Care
.
2015 Jul
;
19
:
266
. .

Additional information

Institut of conduction of work: Pulmonary Rehabilitation Program, Hospital Universitário de Brasília, Av L2norte SGAN 604/605, Brasília-DF/Brazil, Universidade de Brasília, Brasília 70840-901 (Brazil).

Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.